featured
Adalimumab in Japanese Patients With Active Pyoderma Gangrenosum Ulcers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52-week phase 3 open-label study
J Dermatol 2022 Mar 03;[EPub Ahead of Print], K Yamasaki, K Yamanaka, Y Zhao, S Iwano, K Takei, K Suzuki, T YamamotoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.